Bayer denies firm plans to cut jobs in German pharma

Bayer denied a magazine report it has concrete plans to slash up to 700 jobs at its pharma operations in Germany; the company said it is negotiating with labor leaders and cuts haven't been finalized. Report

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.